Boumelha J, de Castro A, Bah N, Cha H, et al. CRISPR-Cas9 screening identifies KRAS-induced COX-2 as a driver of immunotherapy resistance in lung cancer. Cancer Res 2024 Apr 18. doi: 10.1158/0008-5472.CAN-23-2627.
PMID: 38635884